Table 3.
Baseline Variables | Univariate Analysis |
Multivariate Analysis |
||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Groupa | 0.524 | 0.282-0.975 | .031 | 0.658 | 0.377-0.982 | .023 |
Maximum tumor sizeb | 1.156 | 1.046-1.277 | .004 | 1.152 | 1.020-1.302 | .019 |
Tumor numberc | 0.632 | 0.401-0.998 | .029 | 0.629 | 0.386-0.987 | .034 |
Albumin | 0.937 | 0.883-0.995 | .033 | |||
AST | 1.007 | 1.001-1.014 | .029 | |||
TBIL | 1.048 | 1.008-1.089 | .018 | |||
DBIL | 1.101 | 1.040-1.166 | .031 |
Abbreviations: HR, hazard ratio; CI, confidence interval; AST, aspartate transaminase; TBIL, total bilirubin; DBIL, direct bilirubin; AFP, α-fetorpotein; TACE, transarterial chemoembolization; KA, Kang’ai injection.
Group: TACE + KA = 2, TACE = 1.
Maximum tumor size: 3.1-5.0 cm=1, 5.1-10.0 cm = 2, ≥10.1 cm = 3.
Tumor number: 1 tumor = 1, 2-3 tumors = 2, ≥4 tumors = 3.